Abstract:Background Traditional tumor thermal ablations, such as radiofrequency ablation (RFA) and cryoablation, can result in good local control of tumor, but traditional tumor thermal ablations are limited by poor long-term survival due to the failure of control of distal metastasis. Our previous studies developed a novel cryo-thermal therapy to treat the B16F10 melanoma mouse model. Long-term survival and T-cell-mediated durable antitumor immunity were achieved after cryo-thermal therapy, but whether tumor antigen-specific T-cells were augmented by cryo-thermal therapy was not determined.Methods The long-term antitumor therapeutic efficacy of cryo-thermal therapy was performed in B16F10 murine melanoma models. Splenocytes derived from mice treated with RFA or cryo-thermal therapy were coincubated with tumor antigen peptides to detect the frequency of antigen specific CD4+ and CD8+ T-cells by flow cytometry. Splenocytes were then stimulated and expanded by αCD3 or peptides and adoptive T-cell therapy experiments were performed to identify the antitumor efficacy of T-cells induced by RFA and cryo-thermal therapy. Naïve mice and tumor-bearing mice were used as control groups.Results Local cryo-thermal therapy generated a stronger systematic antitumor immune response than RFA and a long-lasting antitumor immunity that protected against tumor rechallenge. In vitro studies showed that the antigen-specific CD8+ T-cell response was induced by both cryo-thermal therapy and RFA, but the strong neoantigen-specific CD4+ T-cell response was only induced by cryo-thermal therapy. Cryo-thermal therapy-induced strong antitumor immune response was mainly mediated by CD4+ T-cells, particularly neoantigen-specific CD4+ T-cells.Conclusion Cryo-thermal therapy induced a stronger and broader antigen-specific memory T-cells. Specifically, cryo-thermal therapy, but not RFA, led to a strong neoantigen-specific CD4+ T-cell response that mediated the resistance to tumor challenge.

Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy

Th1-Dominant CD4+ T Cells Orchestrate Endogenous Systematic Antitumor Immune Memory After Cryo-Thermal Therapy

Downregulated TNF-α Levels after Cryo-Thermal Therapy Drive Tregs Fragility to Promote Long-Term Antitumor Immunity.

Neutrophils Promote the Activation of Monocytes Via ROS to Boost Systemic Antitumor Immunity after Cryo-Thermal Therapy

Research progress on anti-tumor immune effect of cryoablation

Adoptive CD8+ T cell therapy against cancer:Challenges and opportunities

Progress in the cryoablation and cryoimmunotherapy for tumor

Cryo-thermal Therapy Elicits Potent Anti-Tumor Immunity by Inducing Extracellular Hsp70-dependent MDSC Differentiation

Cryo-thermal Therapy Inducing MI Macrophage Polarization Created CXCL10 and IL-6-rich Pro-Inflammatory Environment for CD4+ T Cell-Mediated Anti-Tumor Immunity.

Natural Killer Cells Reprogram Myeloid-Derived Suppressor Cells to Induce TNF-α Release via NKG2D–Ligand Interaction after Cryo-Thermal Therapy

Cryo-thermal therapy induces macrophage polarization for durable anti-tumor immunity

Modern cancer therapy: cryoablation meets immune checkpoint blockade

Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma

Optimizing Adoptive Cell Therapy for Solid Tumors via Epigenetic Regulation of T‐cell Destiny

Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy

CCL5 Deficiency Enhanced Cryo–Thermal-Triggered Long-Term Anti-Tumor Immunity in 4T1 Murine Breast Cancer

Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes.

A Role of Eosinophils in Mediating the Anti-Tumour Effect of Cryo-Thermal Treatment

Neoantigen-specific CD4+ T-cell Response is Critical for the Therapeutic Efficacy of Cryo-Thermal Therapy

Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors

Combining All-Trans Retinoid Acid Treatment Targeting Myeloid-Derived Suppressive Cells with Cryo-Thermal Therapy Enhances Antitumor Immunity in Breast Cancer.